Võrdle meetodeid

	Drug Attitude Inventory (DAI)	Ravimiuskumuste küsimustik (BMQ)
Valdkond	Farmakoloogia	Farmakoloogia
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	1983	1999
Looja	Thomas P. Hogan, Ahmed G. Awad, and Robert Eastwood	Rob Horne, John Weinman, and Michelle Hankins
Tüüp	Self-report	Self-report
Algallikas	Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13(1), 177-183.	Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1-24.
Rööpnimetused	DAI, DAI-10, DAI-30	BMQ
Seotud	4	4
Kokkuvõte	The Drug Attitude Inventory (DAI) is a brief self-report measure developed by Hogan, Awad, and Eastwood in 1983 to assess attitudes toward medication and predicted medication compliance in schizophrenia and other psychiatric conditions. The original 30-item version (DAI-30) and the widely used 10-item short form (DAI-10) capture patients' subjective experience of medication benefit, side effects, and overall willingness to take medication as a predictor of adherence. The DAI is particularly valuable in psychiatric care, where attitudes toward antipsychotic and antidepressant medications strongly predict adherence and clinical outcomes.	The Beliefs about Medicines Questionnaire (BMQ) is an 18-item self-report measure developed by Horne, Weinman, and Hankins in 1999 to assess patients' cognitive beliefs about necessity of medications and concerns about potential adverse effects. It is widely used in clinical research to predict medication adherence, particularly in chronic disease management, and has demonstrated strong predictive validity across diverse populations and disease contexts.